Advertisement

Pharmacy

Including inpatient and outpatient environments, hospitals and health systems can expect a 4.57 percent increase in pharmaceutical spending next year, according to Vizient's July 2019 drug price forecast.

OxyContin maker Purdue Pharma plans to close its manufacturing plant in Durham, N.C., by the end of the year, according to the Stamford Advocate.

Advertisement

The FDA has approved Turalio, the first therapy for adult patients with a rare, nonmalignant tumor that affects joints and causes severe morbidity.

RWJBarnabas Health System developed a specialized pharmacy team for its intensive care unit that has reduced medication wait times and potential drug errors in critical care settings, according to a new study published in the Journal of Clinical Outcomes.

CMS issued its annual Inpatient Prospective Payment System final rule Aug. 2, which includes boosting reimbursements to hospitals for expensive new medical technologies, including last-resort cancer treatments known as CAR-T therapies.

Advertisement